Uncategorized Morgan Stanley Lifts Performance Food Group Company (PFGC) Stock Target to $93 Post Content
Uncategorized Gyre Therapeutics, Inc. (GYRE) Raises $23M in Public Stock Offering to Fund Liver Fibrosis Trials Post Content
Uncategorized Silexion Therapeutics Corp (SLXN)’s RNAi Therapy Blocks 90% of Colorectal Tumors Post Content
Uncategorized Cytek Biosciences, Inc. (CTKB) Elevates Cell Analysis with New Aurora Evo System Post Content